BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 25304184)

  • 1. JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy.
    Khasabova IA; Yao X; Paz J; Lewandowski CT; Lindberg AE; Coicou L; Burlakova N; Simone DA; Seybold VS
    Pharmacol Res; 2014 Dec; 90():67-75. PubMed ID: 25304184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
    Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
    Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral deficiency and antiallodynic effects of 2-arachidonoyl glycerol in a mouse model of paclitaxel-induced neuropathic pain.
    Thomas A; Okine BN; Finn DP; Masocha W
    Biomed Pharmacother; 2020 Sep; 129():110456. PubMed ID: 32603895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing 2-arachidonoyl glycerol signaling in the periphery attenuates mechanical hyperalgesia in a model of bone cancer pain.
    Khasabova IA; Chandiramani A; Harding-Rose C; Simone DA; Seybold VS
    Pharmacol Res; 2011 Jul; 64(1):60-7. PubMed ID: 21440630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB₁ and CB₂ receptors.
    Desroches J; Charron S; Bouchard JF; Beaulieu P
    Neuropharmacology; 2014 Feb; 77():441-52. PubMed ID: 24148808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral antinociceptive effects of inhibitors of monoacylglycerol lipase in a rat model of inflammatory pain.
    Guindon J; Guijarro A; Piomelli D; Hohmann AG
    Br J Pharmacol; 2011 Aug; 163(7):1464-78. PubMed ID: 21198549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy.
    Khasabova IA; Khasabov S; Paz J; Harding-Rose C; Simone DA; Seybold VS
    J Neurosci; 2012 May; 32(20):7091-101. PubMed ID: 22593077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tingenone, a pentacyclic triterpene, induces peripheral antinociception due to cannabinoid receptors activation in mice.
    Veloso CC; Ferreira RCM; Rodrigues VG; Duarte LP; Klein A; Duarte ID; Romero TRL; Perez AC
    Inflammopharmacology; 2018 Feb; 26(1):227-233. PubMed ID: 28889355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain.
    Kinsey SG; Long JZ; O'Neal ST; Abdullah RA; Poklis JL; Boger DL; Cravatt BF; Lichtman AH
    J Pharmacol Exp Ther; 2009 Sep; 330(3):902-10. PubMed ID: 19502530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined inhibition of monoacylglycerol lipase and cyclooxygenases synergistically reduces neuropathic pain in mice.
    Crowe MS; Leishman E; Banks ML; Gujjar R; Mahadevan A; Bradshaw HB; Kinsey SG
    Br J Pharmacol; 2015 Apr; 172(7):1700-12. PubMed ID: 25393148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The monoacylglycerol lipase inhibitor JZL184 attenuates LPS-induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action.
    Kerr DM; Harhen B; Okine BN; Egan LJ; Finn DP; Roche M
    Br J Pharmacol; 2013 Jun; 169(4):808-19. PubMed ID: 23043675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms.
    Spradley JM; Guindon J; Hohmann AG
    Pharmacol Res; 2010 Sep; 62(3):249-58. PubMed ID: 20416378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats.
    Sciolino NR; Zhou W; Hohmann AG
    Pharmacol Res; 2011 Sep; 64(3):226-34. PubMed ID: 21600985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoacylglycerol lipase (MAGL) inhibition attenuates acute lung injury in mice.
    Costola-de-Souza C; Ribeiro A; Ferraz-de-Paula V; Calefi AS; Aloia TP; Gimenes-Júnior JA; de Almeida VI; Pinheiro ML; Palermo-Neto J
    PLoS One; 2013; 8(10):e77706. PubMed ID: 24204926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of anticipatory nausea in a rat model of contextually elicited conditioned gaping by enhancement of the endocannabinoid system.
    Limebeer CL; Abdullah RA; Rock EM; Imhof E; Wang K; Lichtman AH; Parker LA
    Psychopharmacology (Berl); 2014 Feb; 231(3):603-12. PubMed ID: 24043345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal administration of the monoacylglycerol lipase inhibitor JZL184 produces robust inhibitory effects on nociceptive processing and the development of central sensitization in the rat.
    Woodhams SG; Wong A; Barrett DA; Bennett AJ; Chapman V; Alexander SP
    Br J Pharmacol; 2012 Dec; 167(8):1609-19. PubMed ID: 22924700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of CB
    Karwad MA; Couch DG; Theophilidou E; Sarmad S; Barrett DA; Larvin M; Wright KL; Lund JN; O'Sullivan SE
    FASEB J; 2017 Aug; 31(8):3267-3277. PubMed ID: 28404744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain.
    Malek N; Kostrzewa M; Makuch W; Pajak A; Kucharczyk M; Piscitelli F; Przewlocka B; Di Marzo V; Starowicz K
    Pharmacol Res; 2016 Sep; 111():251-263. PubMed ID: 27326920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased anandamide uptake by sensory neurons contributes to hyperalgesia in a model of cancer pain.
    Khasabova IA; Holman M; Morse T; Burlakova N; Coicou L; Harding-Rose C; Simone DA; Seybold VS
    Neurobiol Dis; 2013 Oct; 58():19-28. PubMed ID: 23644187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice.
    Booker L; Kinsey SG; Abdullah RA; Blankman JL; Long JZ; Ezzili C; Boger DL; Cravatt BF; Lichtman AH
    Br J Pharmacol; 2012 Apr; 165(8):2485-96. PubMed ID: 21506952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.